β3 agonists

Papers on β3 agonists

2 papers1 new in 30 days

Friday, November 6

JAMA Network Open

Bladder drugs presumed safer not linked to lower dementia risk

Estimated 10-year dementia risk was 20.0% with mirabegron or vibegron, compared with 18.1% with drugs classified as high-risk anticholinergics.Estimated 10-year dementia risk was 20.0% with mirabegron or vibegron, compared with 18.1% with drugs classified as high-risk anticholinergics.

Figure from JAMA Network Open
Cohort · 830,393 peopleIncident dementia

Sunday, August 21